<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Hereditary Cancer | Seppälä Lab</title><link>https://www.seppalalab.org/tag/hereditary-cancer/</link><atom:link href="https://www.seppalalab.org/tag/hereditary-cancer/index.xml" rel="self" type="application/rss+xml"/><description>Hereditary Cancer</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en</language><lastBuildDate>Fri, 27 Mar 2026 00:00:00 +0000</lastBuildDate><image><url>https://www.seppalalab.org/media/logo_hu_e3f0d28ad302f75b.png</url><title>Hereditary Cancer</title><link>https://www.seppalalab.org/tag/hereditary-cancer/</link></image><item><title>Colorectal Cancer Awareness Month: Burak Yavuz speaks with Toni Seppälä</title><link>https://www.seppalalab.org/post/2026-eocrc-escp-interview/</link><pubDate>Fri, 27 Mar 2026 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/post/2026-eocrc-escp-interview/</guid><description>&lt;p&gt;During Colorectal Cancer Awareness Month, Burak Yavuz sat down with Toni Seppälä for an 8-minute discussion hosted by the European Society of Coloproctology (ESCP), focused on one of the most pressing challenges in colorectal cancer today: the rising incidence of early-onset colorectal cancer (EOCRC).&lt;/p&gt;
&lt;p&gt;Burak asks Toni about the key drivers behind the increasing global incidence, how to distinguish hereditary syndromes from apparently sporadic cases, whether current genetic assessment strategies are keeping pace, and which red flags in younger patients should prompt earlier investigation in daily practice.&lt;/p&gt;
&lt;div style="position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden;"&gt;
&lt;iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen" loading="eager" referrerpolicy="strict-origin-when-cross-origin" src="https://www.youtube.com/embed/67TYYbOPG8U?autoplay=0&amp;amp;controls=1&amp;amp;end=0&amp;amp;loop=0&amp;amp;mute=0&amp;amp;start=0" style="position: absolute; top: 0; left: 0; width: 100%; height: 100%; border:0;" title="YouTube video"&gt;&lt;/iframe&gt;
&lt;/div&gt;</description></item><item><title>The PREDI-LYNCH project</title><link>https://www.seppalalab.org/project/predi-lynch/</link><pubDate>Thu, 01 Jan 2026 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/project/predi-lynch/</guid><description>&lt;p&gt;The PREDI-LYNCH project is dedicated to advancing early detection and personalized prevention of Lynch syndrome, a hereditary condition that predisposes individuals to colorectal, endometrial, and several other types of cancer.&lt;/p&gt;
&lt;p&gt;Through collaboration with leading medical institutions and researchers, the project aims to refine risk assessment tools that combine genetic markers, family history, and lifestyle factors. This holistic approach enables healthcare providers to offer tailored screening and prevention strategies, ultimately reducing cancer incidence and improving long-term patient outcomes.&lt;/p&gt;
&lt;p&gt;PREDI-LYNCH also emphasizes patient education and accessibility, ensuring that risk prediction tools are user-friendly and available to diverse populations. By bridging the gap between research and clinical practice, the PREDI-LYNCH project strives to empower individuals and clinicians alike with actionable insights for precision medicine in hereditary cancer prevention.&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Duration:&lt;/strong&gt; 2025–2031&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Role:&lt;/strong&gt; Leader of clinical studies&lt;/li&gt;
&lt;/ul&gt;</description></item></channel></rss>